Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter De Cruz

Showing results (41-50 of 128) with videos related to

Pageof 13
Sort By:
The Medical Journal of Australia|October 22, 2013
Crohn’s disease: towards improving postsurgical outcomesTrevor J Lockett, Michael A Kamm, Peter De Cruz, et al.
Inflammatory Bowel Diseases|August 31, 2010
Dysplastic lesions in ulcerative colitis: changing paradigmsPatrick B Allen, Michael A Kamm, Peter De Cruz, et al.
Intestinal Research|May 15, 2024
What to do when traditional rescue therapies fail in acute severe ulcerative colitisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitisPatrick Hilley, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|January 17, 2020
Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical OutcomesMatthew Peverelle, Sarang Paleri, Jed Hughes, et al.
ACG Case Reports Journal|July 17, 2023
Novel Use of the Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition for the Treatment of Crohn's Disease During PregnancyBianca Ukovic, Brooke Chapman, Julien Schulberg, et al.
Inflammatory Bowel Diseases|April 28, 2012
Mucosal healing in Crohn's disease: a systematic reviewPeter De Cruz, Michael A Kamm, Lani Prideaux, et al.
Inflammatory Bowel Diseases|April 15, 2026
Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping reviewSimone Chin, Kathryn Demase, Crispin Corte, et al.
Journal of Gastroenterology and Hepatology|January 24, 2023
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of dosesAshish Srinivasan, Peter De Cruz, Melissa Sam, et al.
Scandinavian Journal of Gastroenterology|May 17, 2017
Health care costs associated with Australian tertiary inflammatory bowel disease careBelinda Jackson, Danny Con, Ronald Ma, et al.
Pageof 13

Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
The Medical Journal of Australia|October 22, 2013
Crohn’s disease: towards improving postsurgical outcomesTrevor J Lockett, Michael A Kamm, Peter De Cruz, et al.
Inflammatory Bowel Diseases|August 31, 2010
Dysplastic lesions in ulcerative colitis: changing paradigmsPatrick B Allen, Michael A Kamm, Peter De Cruz, et al.
Intestinal Research|May 15, 2024
What to do when traditional rescue therapies fail in acute severe ulcerative colitisChristopher F D Li Wai Suen, Matthew C Choy, Peter De Cruz
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Upadacitinib in end stage renal disease: A case of acute severe ulcerative colitisPatrick Hilley, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|January 17, 2020
Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical OutcomesMatthew Peverelle, Sarang Paleri, Jed Hughes, et al.
ACG Case Reports Journal|July 17, 2023
Novel Use of the Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition for the Treatment of Crohn's Disease During PregnancyBianca Ukovic, Brooke Chapman, Julien Schulberg, et al.
Inflammatory Bowel Diseases|April 28, 2012
Mucosal healing in Crohn's disease: a systematic reviewPeter De Cruz, Michael A Kamm, Lani Prideaux, et al.
Inflammatory Bowel Diseases|April 15, 2026
Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping reviewSimone Chin, Kathryn Demase, Crispin Corte, et al.
Journal of Gastroenterology and Hepatology|January 24, 2023
Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of dosesAshish Srinivasan, Peter De Cruz, Melissa Sam, et al.
Scandinavian Journal of Gastroenterology|May 17, 2017
Health care costs associated with Australian tertiary inflammatory bowel disease careBelinda Jackson, Danny Con, Ronald Ma, et al.
Pageof 13